Medtronic Inc. (MDT) posted weaker sales in its core defibrillator business in the October quarter, while the company's total revenue rose 4.1%. "Medtronic Sales Drop in Core Pacemaker Business -- Update," at 10:11 a.m. EST, incorrectly said pacemaker sales declined and said revenue increased 5%.

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Medtronic (NYSE:MDT)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Medtronic Charts.
Medtronic (NYSE:MDT)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Medtronic Charts.